Local carboplatin delivery and tissue distribution in livers after radiofrequency ablation

Journal of Biomedical Materials Research - Part A

Volumn 67, Issue 2, 2003, Pages 510-516

  Szymanski Exner, A ^a   Gallacher, A ^b   Stowe, N T ^c   Weinberg, B ^a   Haaga, J R ^d   Gao, J ^a,d  

^a Case Western Reserve University   (United States)

^b Department of Analytical Chemistry LLC ^*  (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Atomic absorption spectroscopy; Drug delivery; Pharmacokinetics; Radiofrequency ablation; Tissue distribution

Indexed keywords

ABLATION; ABSORPTION SPECTROSCOPY; ATOMIC SPECTROSCOPY; BLOOD; DRUG PRODUCTS; HISTOLOGY; PHARMACOKINETICS; TISSUE;

DELIVERY RATES;

BIOMEDICAL ENGINEERING;

ANTINEOPLASTIC AGENT; BUPRENORPHINE; CARBOPLATIN; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CALCULATION; CANCER CELL; CATHETER ABLATION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; HYPOTHESIS; IMPLANT; LIVER; LIVER CANCER; LIVER HISTOLOGY; MALE; MINIMAL RESIDUAL DISEASE; NECROSIS; NONHUMAN; PERFUSION; RAT; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION; SUSTAINED RELEASE FORMULATION; TISSUE DISTRIBUTION; TISSUE INJURY; TISSUE STRUCTURE; VASCULARIZATION;

EID: 0347384104     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10038     Document Type: Article

References (18)

1. Becker GJ. 2000 RSNA annual oration in diagnostic radiology: The future of interventional radiology. Radiology 2001;220:281-292.
2. Lewin JS, Connell CF, Duerk JL, Chung YC, Clampitt ME, Spisak J, Gazelle GS, Haaga JR. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 1998;8:40-47.
3. Dodd GD III, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, Gillams AR, Karahan OI, Rhim H. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000;20:9-27.
4. Rhim H, Dodd GD III. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999;27:221-229.
5. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000;88:2452-2463.
6. Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 2001;48:359-367.
7. Bartolozzi C, Crocetti L, Cioni D, Donati FM, Lencioni R. Assessment of therapeutic effect of liver tumor ablation procedures. Hepatogastroenterology 2001;48:352-358.
8. Boaz TL, Lewin JS, Chung YC, Duerk JL, Clampitt ME, Haaga JR. MR monitoring of MR-guided radiofrequency thermal ablation of normal liver in an animal model. J Magn Reson Imaging 1998;8:64-69.
9. Qian F, Szymanski A, Gao J. Fabrication and Characterization of Controlled Release Poly(D,L-Lactide-co-Glycolide) Millirods. J Biomed Mater Res 2001;55:512-522.
10. Au JLS, Jang SH, Wientjes MG. Clinical aspects of drug delivery to tumors. J Control Release 2002;78:81-95.
11. Kuh HJ, Jang SH, Wientjes MG, Weaver JR, Au JLS. Determinants of Paclitaxel Penetration and Accumulation in Human Solid Tumor. J Positron Emission Tomogr 1999;290:871-880.
12. Jang SH, Wientjes MG, Au JLS. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. J Positron Emission Tomogr 2001; 296:1035-1042.
13. Duffull SB, Robinson BA. Clinical pharmacokinetics and dose optimisation of carboplatin. Clin Pharmacokinet 1997;33:161-83.
14. Milacic R, Cemazar M, Sersa G. Determination of platimun in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry. J Pharm Biomed Anal 1997;16:343-348.
15. Meerum Terwogt JM, Tibben MM, Welbank H, Schellens JH, Beijnen JH. Validated method for the determination of platinum from a liposomal source (SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry. Fresenius J Anal Chem 2000;366:298-302.
16. Shugar GJ. Atomic Absorption Spectroscopy. In: Shugar R, Bauman L, Shugar-Bauman R, editors. Chemical technicians' ready reference handbook, 3rd ed. New York: McGraw-Hill, Inc.; 1990. p 751-763.
17. Szymanski-Exner A, Stowe NT, Lazebnik RS, Salem KA, Wilson DL, Haaga JR, Gao J. Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using x-ray computed tomography. J Control Release 2002;83:415-425.
18. Pauser S, Wagner S, Lippmann M, Pohlen U, Reszka R, Wolf KJ. Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring: An experimental study on the VX2 tumor in the rabbit liver. Cancer Res 1996;56:1863-1867.